117 related articles for article (PubMed ID: 28379396)
1. Trends in occupational disparities for exposure to carcinogenic, mutagenic and reprotoxic chemicals in France 2003-10.
Havet N; Penot A; Morelle M; Perrier L; Charbotel B; Fervers B
Eur J Public Health; 2017 Jun; 27(3):425-432. PubMed ID: 28379396
[TBL] [Abstract][Full Text] [Related]
2. Varied exposure to carcinogenic, mutagenic, and reprotoxic (CMR) chemicals in occupational settings in France.
Havet N; Penot A; Morelle M; Perrier L; Charbotel B; Fervers B
Int Arch Occup Environ Health; 2017 Feb; 90(2):227-241. PubMed ID: 28074269
[TBL] [Abstract][Full Text] [Related]
3. Trends in the Control Strategies for Occupational Exposure to Carcinogenic, Mutagenic, and Reprotoxic Chemicals in France (2003-2010).
Havet N; Penot A; Plantier M; Morelle M; Fervers B; Charbotel B
Ann Work Expo Health; 2019 May; 63(5):488-504. PubMed ID: 31051043
[TBL] [Abstract][Full Text] [Related]
4. Do regulations protect workers from occupational exposures to carcinogenic, mutagenic and reprotoxic (CMR) agents in France?
Havet N; Penot A; Plantier M; Charbotel B; Morelle M; Fervers B
Occup Environ Med; 2018 May; 75(5):389-397. PubMed ID: 29223968
[TBL] [Abstract][Full Text] [Related]
5. Inequalities in the control of the occupational exposure in France to carcinogenic, mutagenic and reprotoxic chemicals.
Havet N; Penot A; Plantier M; Charbotel B; Morelle M; Fervers B
Eur J Public Health; 2019 Feb; 29(1):140-147. PubMed ID: 30060170
[TBL] [Abstract][Full Text] [Related]
6. [Night workers' exposure to harshness factors in France: Lessons learned from the 2010 SUMER Survey].
Havet N; Huguet M; Tonietta J
Rev Epidemiol Sante Publique; 2017 Nov; 65(6):397-407. PubMed ID: 29066032
[TBL] [Abstract][Full Text] [Related]
7. Trends in exposures to physically demanding working conditions in France in 2003, 2010 and 2017.
Havet N; Penot A
Eur J Public Health; 2022 Feb; 32(1):73-79. PubMed ID: 34788439
[TBL] [Abstract][Full Text] [Related]
8. Disparate exposure to physically demanding working conditions in France.
Havet N; Fournier J; Stefanelli J; Plantier M; Penot A
Rev Epidemiol Sante Publique; 2020 Nov; 68(6):327-336. PubMed ID: 33139128
[TBL] [Abstract][Full Text] [Related]
9. Collective Protection Measures for Occupational Exposure to Carcinogenic Chemicals in France: The Links between Regulations on Chemicals and Effective Implementation.
Havet N; Penot A
Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886405
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a chemical risk assessment method of South Korea for chemicals classified as carcinogenic, mutagenic or reprotoxic (CMR).
Kim MU; Byeon SH
Int J Occup Med Environ Health; 2018 Jul; 31(4):491-501. PubMed ID: 29269952
[TBL] [Abstract][Full Text] [Related]
11. Working conditions and occupational risk exposure in employees driving for work.
Fort E; Ndagire S; Gadegbeku B; Hours M; Charbotel B
Accid Anal Prev; 2016 Apr; 89():118-27. PubMed ID: 26859318
[TBL] [Abstract][Full Text] [Related]
12. Occupational co-exposure to biomechanical factors and neurotoxic chemicals in a representative sample of French employees.
Bertin M; Nguyen TH; Bonvallot N; Bodin J; Roquelaure Y
J Occup Health; 2020 Jan; 62(1):e12090. PubMed ID: 31747116
[TBL] [Abstract][Full Text] [Related]
13. The traceability of carcinogenic occupational risks: state of progress in France compared with other European countries.
Fantoni-Quinton S; Frimat P
Med Law; 2010 Dec; 29(4):467-86. PubMed ID: 22145545
[TBL] [Abstract][Full Text] [Related]
14. Contribution of working conditions to occupational inequalities in depressive symptoms: results from the national French SUMER survey.
Niedhammer I; Lesuffleur T; Coutrot T; Chastang JF
Int Arch Occup Environ Health; 2016 Aug; 89(6):1025-37. PubMed ID: 27197816
[TBL] [Abstract][Full Text] [Related]
15. [Carcinogenic and mutagenic agents in the workplace, Poland, 2011-2012].
Pałaszewska-Tkacz A; Czerczak S; Konieczko K
Med Pr; 2015; 66(1):29-38. PubMed ID: 26016043
[TBL] [Abstract][Full Text] [Related]
16. [Occupational carcinogens and mutagens in Poland - occurrence and workers' exposure in the years 2018-2021 based on the data from Central register of carcinogenic or mutagenic agents].
Klimecka A; Konieczko K; Szczęsna D; Jurewicz J
Med Pr; 2023 Dec; 74(5):399-407. PubMed ID: 38104340
[TBL] [Abstract][Full Text] [Related]
17. [Carcinogenic or mutagenic chemical substances and technological processes in the workplace in Poland in 2013-2017].
Niepsuj A; Czerczak S; Konieczko K
Med Pr; 2020 Mar; 71(2):187-203. PubMed ID: 32225180
[TBL] [Abstract][Full Text] [Related]
18. Exposure to occupational carcinogens in great britain.
Cherrie JW; Van Tongeren M; Semple S
Ann Occup Hyg; 2007 Nov; 51(8):653-64. PubMed ID: 17974550
[TBL] [Abstract][Full Text] [Related]
19. [Pediatric exposure to endocrine disruptors and carcinogenic, mutagenic or reprotoxic substances by pharmaceutical forms intended for the cutaneous route: Regulatory provisions in France, in Europe, and state of the art of scientific knowledge].
Trouillard A; Sabri A; Prot-Labarthe S; Storme T; Bourrat E; Soulairol I
Ann Pharm Fr; 2022 Jul; 80(4):426-439. PubMed ID: 34481784
[TBL] [Abstract][Full Text] [Related]
20. The contribution of occupational factors to social inequalities in health: findings from the national French SUMER survey.
Niedhammer I; Chastang JF; David S; Kelleher C
Soc Sci Med; 2008 Dec; 67(11):1870-81. PubMed ID: 18851892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
